About LifeMine Therapeutics
LifeMine Therapeutics is a clinical-stage biopharmaceutical company pioneering Top-Down Drug Discovery™, which leverages evolutionary insights from fungi to discover and develop next-generation precision medicines. Its data-immersive platform integrates genomics, AI, bioinformatics, and synthetic biology to mine genetically-encoded small molecules (GEMs) from the biosphere. The company's lead program, LIFE-001, is a novel calcineurin activation inhibitor in clinical development for the prevention of organ transplant rejection.
Company details
Funding
Total raised
$300M
Last stage
Series C
Investors
Founders
Gregory Verdine
Renowned scientist and biotech entrepreneur; Erving Professor at Harvard University and Harvard Medical School; serial founder of multiple NASDAQ-listed biotech companies including Enanta, Wave Life Sciences, and Aileron.
LinkedInRichard Klausner
Renowned physician-scientist; also founder/co-founder of Juno Therapeutics, GRAIL, Mindstrong, Altos Labs, and Lyell Immunopharma.
WeiQing Zhou
Entrepreneur and company-builder; previously entrepreneur-in-residence at WuXi Healthcare Ventures.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.